FDA Inspection 1152318 — Ablynx NV
The FDA completed an inspection of Ablynx NV on February 9, 2021 in Gent. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 9, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Gent (Belgium)
Additional Details
Mutual Recognition Agreement (MRA)